Cigna Group $CI Shares Sold by Sigma Planning Corp

Sigma Planning Corp lessened its position in shares of Cigna Group (NYSE:CI) by 23.5% during the second quarter, HoldingsChannel reports. The institutional investor owned 1,559 shares of the health services provider’s stock after selling 480 shares during the quarter. Sigma Planning Corp’s holdings in Cigna Group were worth $515,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Flaharty Asset Management LLC purchased a new position in shares of Cigna Group during the first quarter worth approximately $28,000. 1248 Management LLC acquired a new stake in Cigna Group during the 1st quarter worth $29,000. Solstein Capital LLC acquired a new stake in Cigna Group during the 2nd quarter worth $29,000. Activest Wealth Management grew its position in Cigna Group by 360.0% during the 1st quarter. Activest Wealth Management now owns 92 shares of the health services provider’s stock worth $30,000 after purchasing an additional 72 shares during the last quarter. Finally, Chilton Capital Management LLC acquired a new position in Cigna Group in the second quarter valued at $30,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Stock Up 3.2%

Cigna Group stock opened at $264.54 on Friday. The stock’s 50 day moving average price is $293.24 and its 200 day moving average price is $303.54. Cigna Group has a 1-year low of $239.51 and a 1-year high of $350.00. The company has a market cap of $70.66 billion, a PE ratio of 14.44, a price-to-earnings-growth ratio of 0.88 and a beta of 0.44. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.71 and a quick ratio of 0.71.

Cigna Group (NYSE:CI) last released its quarterly earnings data on Thursday, October 30th. The health services provider reported $7.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.64 by $0.19. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The firm had revenue of $69.57 billion during the quarter, compared to analysts’ expectations of $66.40 billion. During the same quarter in the prior year, the business posted $7.51 earnings per share. Cigna Group’s revenue was up 9.5% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, sell-side analysts predict that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 18th. Investors of record on Thursday, December 4th will be paid a $1.51 dividend. The ex-dividend date is Thursday, December 4th. This represents a $6.04 annualized dividend and a dividend yield of 2.3%. Cigna Group’s dividend payout ratio (DPR) is 26.64%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on CI shares. Barclays decreased their target price on shares of Cigna Group from $383.00 to $300.00 and set an “overweight” rating for the company in a research note on Friday, October 31st. Truist Financial decreased their price objective on Cigna Group from $375.00 to $310.00 in a research report on Friday, October 31st. Robert W. Baird set a $372.00 target price on Cigna Group in a research note on Thursday, August 14th. TD Cowen cut their price target on Cigna Group from $387.00 to $333.00 and set a “buy” rating for the company in a research note on Tuesday, November 4th. Finally, The Goldman Sachs Group decreased their price target on Cigna Group from $370.00 to $330.00 and set a “buy” rating for the company in a report on Tuesday. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $339.73.

Insiders Place Their Bets

In other Cigna Group news, insider Brian C. Evanko sold 5,368 shares of the company’s stock in a transaction dated Friday, October 3rd. The shares were sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the transaction, the insider directly owned 51,182 shares in the company, valued at approximately $15,354,600. This represents a 9.49% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO David Cordani purchased 4,134 shares of Cigna Group stock in a transaction dated Monday, November 3rd. The shares were bought at an average price of $241.88 per share, with a total value of $999,931.92. Following the completion of the transaction, the chief executive officer owned 157,935 shares in the company, valued at approximately $38,201,317.80. This trade represents a 2.69% increase in their position. The SEC filing for this purchase provides additional information. 0.70% of the stock is currently owned by company insiders.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.